APO RESEARCH · REPORT
Hemostatic Agents
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Product & engineering
Understand the product.
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Selected research
Industry Research
Hemostatic Agents Industry Research Report 2026
Market perspective
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
Report Scope
Read the full market overview
This report quantifies the global Hemostatic Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemostatic Agents Market by Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Hemostatic Agents Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Hemostatic Agents Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Hemostatic Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemostatic Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gelation Sponge
- Oxidized Regenerated Cellulose Based Hemostats
- Others
Applications
- Hospitals
- Surgical Centers
- Nursing Homes
Companies covered
- Ethicon
- Pfizer
- Baxter International
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences
- B Braun Melsungen
- Gelita Medical
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica
- CryoLife
- BioCer Entwicklungs
- Biom’Up SAS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemostatic Agents Market Size (2021-2032)
- 2.2.2 Global Hemostatic Agents Sales (2021-2032)
- 2.2.3 Global Hemostatic Agents Market Average Price (2021-2032)
- 2.3 Hemostatic Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gelation Sponge
- 2.3.3 Oxidized Regenerated Cellulose Based Hemostats
- 2.3.4 Others
- 2.4 Hemostatic Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Surgical Centers
- 2.4.4 Nursing Homes
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemostatic Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemostatic Agents Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hemostatic Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemostatic Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemostatic Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemostatic Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemostatic Agents, Product Type & Application
- 3.8 Global Manufacturers of Hemostatic Agents, Established Date
- 3.9 Global Hemostatic Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ethicon
- 4.1.1 Ethicon Company Information
- 4.1.2 Ethicon Business Overview
- 4.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ethicon Hemostatic Agents Product Portfolio
- 4.1.5 Ethicon Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Hemostatic Agents Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Baxter International
- 4.3.1 Baxter International Company Information
- 4.3.2 Baxter International Business Overview
- 4.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter International Hemostatic Agents Product Portfolio
- 4.3.5 Baxter International Recent Developments
- 4.4 C. R. Bard
- 4.4.1 C. R. Bard Company Information
- 4.4.2 C. R. Bard Business Overview
- 4.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 C. R. Bard Hemostatic Agents Product Portfolio
- 4.4.5 C. R. Bard Recent Developments
- 4.5 The Medicines Company
- 4.5.1 The Medicines Company Company Information
- 4.5.2 The Medicines Company Business Overview
- 4.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 The Medicines Company Hemostatic Agents Product Portfolio
- 4.5.5 The Medicines Company Recent Developments
- 4.6 Anika Therapeutics
- 4.6.1 Anika Therapeutics Company Information
- 4.6.2 Anika Therapeutics Business Overview
- 4.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Anika Therapeutics Hemostatic Agents Product Portfolio
- 4.6.5 Anika Therapeutics Recent Developments
- 4.7 Advanced Medical Solutions
- 4.7.1 Advanced Medical Solutions Company Information
- 4.7.2 Advanced Medical Solutions Business Overview
- 4.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Advanced Medical Solutions Hemostatic Agents Product Portfolio
- 4.7.5 Advanced Medical Solutions Recent Developments
- 4.8 Integra LifeSciences
- 4.8.1 Integra LifeSciences Company Information
- 4.8.2 Integra LifeSciences Business Overview
- 4.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Integra LifeSciences Hemostatic Agents Product Portfolio
- 4.8.5 Integra LifeSciences Recent Developments
- 4.9 B Braun Melsungen
- 4.9.1 B Braun Melsungen Company Information
- 4.9.2 B Braun Melsungen Business Overview
- 4.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 B Braun Melsungen Hemostatic Agents Product Portfolio
- 4.9.5 B Braun Melsungen Recent Developments
- 4.10 Gelita Medical
- 4.10.1 Gelita Medical Company Information
- 4.10.2 Gelita Medical Business Overview
- 4.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gelita Medical Hemostatic Agents Product Portfolio
- 4.10.5 Gelita Medical Recent Developments
- 4.11 Equimedical
- 4.11.1 Equimedical Company Information
- 4.11.2 Equimedical Business Overview
- 4.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Equimedical Hemostatic Agents Product Portfolio
- 4.11.5 Equimedical Recent Developments
- 4.12 Vascular Solutions
- 4.12.1 Vascular Solutions Company Information
- 4.12.2 Vascular Solutions Business Overview
- 4.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Vascular Solutions Hemostatic Agents Product Portfolio
- 4.12.5 Vascular Solutions Recent Developments
- 4.13 Marine Polymer Technologies
- 4.13.1 Marine Polymer Technologies Company Information
- 4.13.2 Marine Polymer Technologies Business Overview
- 4.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Marine Polymer Technologies Hemostatic Agents Product Portfolio
- 4.13.5 Marine Polymer Technologies Recent Developments
- 4.14 Z-Medica
- 4.14.1 Z-Medica Company Information
- 4.14.2 Z-Medica Business Overview
- 4.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Z-Medica Hemostatic Agents Product Portfolio
- 4.14.5 Z-Medica Recent Developments
- 4.15 CryoLife
- 4.15.1 CryoLife Company Information
- 4.15.2 CryoLife Business Overview
- 4.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CryoLife Hemostatic Agents Product Portfolio
- 4.15.5 CryoLife Recent Developments
- 4.16 BioCer Entwicklungs
- 4.16.1 BioCer Entwicklungs Company Information
- 4.16.2 BioCer Entwicklungs Business Overview
- 4.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 BioCer Entwicklungs Hemostatic Agents Product Portfolio
- 4.16.5 BioCer Entwicklungs Recent Developments
- 4.17 Biom’Up SAS
- 4.17.1 Biom’Up SAS Company Information
- 4.17.2 Biom’Up SAS Business Overview
- 4.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Biom’Up SAS Hemostatic Agents Product Portfolio
- 4.17.5 Biom’Up SAS Recent Developments
5 Global Hemostatic Agents Market Scenario by Region
- 5.1 Global Hemostatic Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemostatic Agents Sales by Region: 2021-2032
- 5.2.1 Global Hemostatic Agents Sales by Region: 2021-2026
- 5.2.2 Global Hemostatic Agents Sales by Region: 2027-2032
- 5.3 Global Hemostatic Agents Revenue by Region: 2021-2032
- 5.3.1 Global Hemostatic Agents Revenue by Region: 2021-2026
- 5.3.2 Global Hemostatic Agents Revenue by Region: 2027-2032
- 5.4 North America Hemostatic Agents Market Facts & Figures by Country
- 5.4.1 North America Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemostatic Agents Sales by Country (2021-2032)
- 5.4.3 North America Hemostatic Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemostatic Agents Market Facts & Figures by Country
- 5.5.1 Europe Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemostatic Agents Sales by Country (2021-2032)
- 5.5.3 Europe Hemostatic Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemostatic Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemostatic Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemostatic Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemostatic Agents Market Facts & Figures by Country
- 5.7.1 South America Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemostatic Agents Sales by Country (2021-2032)
- 5.7.3 South America Hemostatic Agents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemostatic Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemostatic Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemostatic Agents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemostatic Agents Sales by Type (2021-2032)
- 6.1.1 Global Hemostatic Agents Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hemostatic Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Hemostatic Agents Revenue by Type (2021-2032)
- 6.2.1 Global Hemostatic Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemostatic Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemostatic Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemostatic Agents Sales by Application (2021-2032)
- 7.1.1 Global Hemostatic Agents Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hemostatic Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Hemostatic Agents Revenue by Application (2021-2032)
- 7.2.1 Global Hemostatic Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemostatic Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemostatic Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemostatic Agents Value Chain Analysis
- 8.1.1 Hemostatic Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemostatic Agents Production Mode & Process
- 8.2 Hemostatic Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemostatic Agents Distributors
- 8.2.3 Hemostatic Agents Customers
9 Global Hemostatic Agents Analyzing Market Dynamics
- 9.1 Hemostatic Agents Industry Trends
- 9.2 Hemostatic Agents Industry Drivers
- 9.3 Hemostatic Agents Industry Opportunities and Challenges
- 9.4 Hemostatic Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst